Latest News

Episode 15 – A Journey from HIV to Cure with Adam Castillejo, also known as The London Patient, Part 1 Recorded Live at CROI 2024 on March 3, 2024

In this episode of Going anti-Viral, host Dr Michael Saag interviews Adam Castillejo, known as the London patient, who is the second person to have been cured of HIV infection. The discussion, recorded on March 3, 2024, at The Conference on Retroviruses and Opportunistic Infections (CROI), touches on Adam's initial HIV diagnosis in London during [...]
DETAIL

The April 2024 issue of Topics in Antiviral Medicine™ is Now Available

The April 2024 issue of Topics in Antiviral Medicine™ (TAM) is now available at https://www.iasusa.org/tam/april-2024/. This issue offers up to 3.75 CME credits and includes 3 invited reviews on the topics of long COVID; mRNA vaccine technology for SARS-CoV-2 and prospects for an HIV-1 vaccine; and routine and special vaccinations in people with HIV. This issue also […]

DETAIL

Now Available: On-Demand Webcasts for the Annual Update on HIV Management in Atlanta

The on-demand webcasts for the 2024 IAS–USA Annual Update on HIV Management in Atlanta, Georgia, are now available. Information on how to claim CME for the on-demand component will be posted soon. Watch the Webcasts
DETAIL

Latest Update on Urgent Virus Outbreaks: June 2024 Dialogue Now Open For Registration

Latest Update on Urgent Virus Outbreaks: June 2024 Dialogue Now Open For Registration June 11, 2024 10:00 AM – 11:00 AM PT   IAS–USA Dialogues (formerly COVID-19 Dialogues) were created to address an urgent need for reliable scientific information, with understanding of SARS-CoV-2 and COVID-19 disease changing almost daily. In response, the IAS−USA created a program [...]
DETAIL

Partnership Announcement: IAS-USA Collaborates With the World Congress of Epidemiology for 2024

We are excited to announce a collaboration between the IAS–USA and the World Congress of Epidemiology 2024. The partnership is in support of the state-of-the-art HIV Epidemiology content at WCE2024, which will be held in Cape Town, South Africa on September 24 to 27, 2024. A combination of workshops, symposia, interactive sessions, and abstract-driven content […]

DETAIL

Now Available: On-Demand Webcasts for the Annual Update on HIV Management in New York

The on-demand webcasts for the 2024 Scott M. Hammer Annual Update on HIV Management in New York, NY, are now available. This enduring activity offers up to 6.0 CME credits. Continuing Education Credits CME Credits The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical [...]
DETAIL

Claiming CME Credits, ABIM MOC Points, or a Certificate of Participation

All registered attendees received an email on Thursday, March 7, with instructions on how to claim CME credits, ABIM MOC points, or a certificate of participation. These instructions are also available on the CME page.

DETAIL

CROI 2025 in San Francisco, California

Thank you for attending the 2024 Conference on Retroviruses and Opportunistic Infections! We hope you enjoyed this year’s rich scientific program of new research findings, state-of-the-art plenary talks, lively interactive sessions, and comprehensive symposia. CROI 2025 will be held in San Francisco, California from March 9 to 12. Hope to see you again next year!

DETAIL

IN MEMORIAM: Dr John P. Phair

The IAS-USA is deeply saddened by the passing of John P. Phair, MD, on February 19, 2024. John P. Phair, MD, Professor of Medicine, Emeritus, Northwestern University Medical School, Chicago, IL, was the first recipient of the International AIDS Society–USA (IAS–USA) Lifetime Leadership Award. He was honored on April 19, 2010, at the IAS–USA annual [...]
DETAIL

The IAS–USA Guidelines Panel Recommendation on the Use of Cabotegravir and Rilpivirine

In a letter to JAMA published today, March 1, the IAS–USA Guidelines Panel provided its HIV treatment recommendation on the use of cabotegravir and rilpivirine. To learn more about this most recent update, click here. Read the Letter Here
DETAIL